Showing 25–36 of 109 results
Discovery and development of new molecules directed against validated pain targets is required to advance the treatment of pain disorders.…
Read MoreAs key mediators of immune responses, cytokines have emerged as major drug targets for inflammatory and autoimmune diseases. A significant…
Read MoreCheckpoint blockade antibodies are established cancer therapeutics. However, in recent years, agonistic antibodies have emerged as therapeutics not only for…
Read MoreIn this webinar, Eurofins DiscoverX and Latigo Therapeutics come together to present recent advances in ion channel drug discovery focusing…
Read MoreIn this webinar, Eurofins DiscoverX and Latigo Therapeutics come together to present recent advances in ion channel drug discovery focusing…
Watch NowCase studies on the use of cell-based assays that monitor receptor dimerization and signaling reporter activation targeting IL-12, IL-23, IL-15,…
Read MoreDiscover valuable insights on breakthroughs, innovative strategies, and cell-based approaches for immunotherapeutic discovery and development.
Read MoreDiscover valuable insights on breakthroughs, innovative strategies, and cell-based approaches for immunotherapeutic discovery and development.
Read MoreCase studies on the characterization & clinical development of agonistic antibody therapeutics targeting checkpoint receptors.
Read MoreAccelerate the Development of Peptide Therapeutics for Obesity & Diabetes With MOA-Reflective Assays — Assays for Screening, Profiling, Potency, &…
Read MoreJennifer Lin-Jones, Ph.D., Associate Director of Assay Development R&D Department, Eurofins DiscoverX
Read MoreWatch this webinar to discover functional cell-based assays for characterizing novel therapeutics & biosimilars targeting cytokines in inflammation & oncology.
Watch Now
